Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoxia-profile guided nimorazole use during radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma
2015-004133-27Phase 3Active
- Sponsor
- Aarhus University Hospital
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nimorazole in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Locoregional control after radiotherapy. Started Feb 2016; status: active.
02
Drugs
nimorazole
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2015-004133-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004133-27.